Beijing Balance Medical TechnologyLtd Future Growth
Future criteria checks 5/6
Beijing Balance Medical TechnologyLtd is forecast to grow earnings and revenue by 56.4% and 47.9% per annum respectively while EPS is expected to grow by 56.6% per annum.
Key information
56.4%
Earnings growth rate
56.6%
EPS growth rate
Medical Equipment earnings growth | 24.0% |
Revenue growth rate | 47.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 Feb 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 897 | 310 | N/A | N/A | 1 |
12/31/2024 | 571 | 184 | N/A | N/A | 1 |
3/31/2024 | 382 | 112 | N/A | N/A | N/A |
12/31/2023 | 371 | 115 | 13 | 141 | N/A |
9/30/2023 | 332 | 106 | 10 | 137 | N/A |
6/30/2023 | 322 | 102 | 21 | 152 | N/A |
3/31/2023 | 294 | 93 | -11 | 125 | N/A |
12/31/2022 | 295 | 95 | 24 | 129 | N/A |
9/30/2022 | 289 | 71 | 25 | 116 | N/A |
6/30/2022 | 268 | 62 | 22 | 103 | N/A |
3/31/2022 | 266 | 56 | 42 | 86 | N/A |
12/31/2021 | 252 | 51 | 4 | 76 | N/A |
9/30/2021 | 246 | 52 | 14 | 78 | N/A |
6/30/2021 | 240 | 50 | 21 | 73 | N/A |
3/31/2021 | 211 | 56 | 11 | 62 | N/A |
12/31/2020 | 182 | 57 | 43 | 51 | N/A |
9/30/2020 | 158 | 60 | 42 | 48 | N/A |
6/30/2020 | 144 | 64 | 48 | 50 | N/A |
3/31/2020 | 138 | 59 | 53 | 55 | N/A |
12/31/2019 | 146 | 63 | 62 | 64 | N/A |
9/30/2019 | 136 | 44 | 56 | 60 | N/A |
12/31/2018 | 111 | 33 | 52 | 54 | N/A |
12/31/2017 | 92 | 42 | N/A | 46 | N/A |
12/31/2016 | 78 | 31 | N/A | 45 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688198's forecast earnings growth (56.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 688198's earnings (56.4% per year) are forecast to grow faster than the CN market (24.4% per year).
High Growth Earnings: 688198's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688198's revenue (47.9% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 688198's revenue (47.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 688198's Return on Equity is forecast to be high in 3 years time